Dynamiker Biotechnology (Tianjin) Co., Ltd.

Clinical Value of IgG/IgM detection for COVID-19

Table of Content [Hide]

    According to the“Diagnostic and treatment protocol of COVID-19 (7th Version)”, the 2019-nCOV IgG/IgM antibody test is one of the proven diagnostic criteria, to assist the diagnostic of COVID-19. This is a big improvement and supplement of PCR assay.

    Normally IgM appears at early stage of infection and IgG shows later with an increased titer and could exist in blood for a long time. Regarding how to combine 2019-nCoV IgG/IgM test, the National Center for Clinical Laboratories provides authentic interpretation.


    微信截图_20200316110017.png


    References
    We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. Part of the tracking is necessary to ensure SEO effectiveness,
    By using this site, you agree to our use of cookies. Visit our cookie policy to learn more.
    Reject Accept